News

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...
At first glance, Pfizer delivered a strong Q2 and upped its 2025 full-year EPS guidance. Click here to find out why I rate ...
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...
PFIZER said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday.
Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...